Brittany Sleek
Nurse Practitioner · Bremen, GANPI 1669982088
Payments from drug & device makers
Across 319 payments — averaging $15.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$1K
- Pfizer$508
- Lilly USA, LLC$416
- Amgen$397
- GSK$203
- plus $1K from 24 others
What the payments were for
- Food & beverage$5,001100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 65 | $1,076 |
| AbbVie | 100 | $1,021 |
| Pfizer | 27 | $508 |
| Lilly USA, LLC | 18 | $416 |
| Amgen | 25 | $397 |
| GSK | 13 | $203 |
| Novartis | 9 | $186 |
| AstraZeneca | 10 | $140 |
| Amarin Pharma, Inc. | 5 | $114 |
| Sanofi-aventis U.S. LLC | 6 | $112 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $97 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $96 |
| Otsuka America Pharmaceutical, Inc. | 5 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| Dexcom, Inc. | 3 | $74 |
| Astellas Pharma US Inc | 3 | $70 |
| Jazz Pharmaceuticals Inc. | 2 | $46 |
| Lundbeck LLC | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $37 |
| Johnson & Johnson | 2 | $29 |
| Abbott | 1 | $23 |
| Covis Pharma GmbH | 1 | $23 |
| Boehringer Ingelheim | 1 | $21 |
| Shield Therapeutics Inc | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Mylan Specialty L.p. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,001 in reported general payments places this provider in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 122 | $166,477 |
| MounjaroTirzepatide | 68 | $80,560 |
| JardianceEmpagliflozin | 68 | $68,006 |
| EliquisApixaban | 16 | $19,028 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $18,873 |
| VraylarCariprazine Hcl | 14 | $18,850 |
| TrulicityDulaglutide | 15 | $15,822 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 11 | $11,989 |
| Praluent PenAlirocumab | 17 | $11,903 |
| RybelsusSemaglutide | 12 | $10,980 |
| MyrbetriqMirabegron | 19 | $10,813 |
| VascepaIcosapent Ethyl | 22 | $7,703 |
| NamzaricMemantine Hcl/Donepezil Hcl | 11 | $6,647 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $5,540 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $4,359 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,076 | $177,456134 claims |
| Lilly USA, LLCMounjaro, Trulicity | $416 | $96,38283 claims |
| Boehringer IngelheimJardiance | $21 | $68,00668 claims |
| AbbVieVraylar, Namzaric | $1,021 | $25,49725 claims |
| PfizerEliquis | $508 | $19,02816 claims |
| GSKTrelegy Ellipta | $203 | $18,87315 claims |
| Astellas Pharma US IncMyrbetriq | $70 | $10,81319 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $17 | $1,429213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Bremen
- Crystal LogsdonSavannah$566K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
- Jessica AdkinsSavannah$226K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.